DK3158337T3 - Fremgangsmåder til bestemmelse af risiko for type 1-diabetes ved hjælp af serumproteinbiomarkører - Google Patents
Fremgangsmåder til bestemmelse af risiko for type 1-diabetes ved hjælp af serumproteinbiomarkører Download PDFInfo
- Publication number
- DK3158337T3 DK3158337T3 DK15738959.4T DK15738959T DK3158337T3 DK 3158337 T3 DK3158337 T3 DK 3158337T3 DK 15738959 T DK15738959 T DK 15738959T DK 3158337 T3 DK3158337 T3 DK 3158337T3
- Authority
- DK
- Denmark
- Prior art keywords
- diabetes
- methods
- type
- serum protein
- protein biomarkers
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4713—Plasma globulins, lactoglobulin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/775—Apolipopeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20140186 | 2014-06-18 | ||
| PCT/FI2015/050448 WO2015193552A2 (en) | 2014-06-18 | 2015-06-18 | Means and methods for determining risk of type-1 diabetes by serum protein biomarkers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3158337T3 true DK3158337T3 (da) | 2019-05-13 |
Family
ID=53673964
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15738959.4T DK3158337T3 (da) | 2014-06-18 | 2015-06-18 | Fremgangsmåder til bestemmelse af risiko for type 1-diabetes ved hjælp af serumproteinbiomarkører |
| DK19160490.9T DK3517958T3 (da) | 2014-06-18 | 2015-06-18 | Midler og fremgangsmåder til bestemmelse af risikoen for type 1-diabetes med serumproteinbiomarkører |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19160490.9T DK3517958T3 (da) | 2014-06-18 | 2015-06-18 | Midler og fremgangsmåder til bestemmelse af risikoen for type 1-diabetes med serumproteinbiomarkører |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10877034B2 (da) |
| EP (2) | EP3158337B1 (da) |
| DK (2) | DK3158337T3 (da) |
| ES (2) | ES2825573T3 (da) |
| HU (1) | HUE052117T2 (da) |
| PL (2) | PL3517958T3 (da) |
| WO (1) | WO2015193552A2 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114113624A (zh) * | 2020-08-28 | 2022-03-01 | 香港城市大学深圳研究院 | 利用免疫球蛋白关联蛋白质组开发疾病标志物的方法及装置 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1840573A1 (en) * | 2006-03-27 | 2007-10-03 | Institut Pasteur | Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections |
| US8911960B2 (en) | 2009-06-01 | 2014-12-16 | Case Western Reserve University | Method for identifying idiopathic pneumonia progression by measuring the level of mannose-binding protein C |
| US20120177660A1 (en) * | 2011-01-06 | 2012-07-12 | Georgia Health Sciences University Research Institute, Inc. | Biomarkers and therapeutic targets for type 1 diabetes |
| WO2013106851A2 (en) * | 2012-01-13 | 2013-07-18 | Eastern Virginia Medical School | Syncollin, pancreatic triacylglycerol lipase, and other biomarkers for diabetes |
| WO2014015217A1 (en) * | 2012-07-19 | 2014-01-23 | Vertex Pharmaceuticals Incorporated | Biomarkers for hcv infected patients |
-
2015
- 2015-06-18 ES ES19160490T patent/ES2825573T3/es active Active
- 2015-06-18 WO PCT/FI2015/050448 patent/WO2015193552A2/en active Application Filing
- 2015-06-18 PL PL19160490T patent/PL3517958T3/pl unknown
- 2015-06-18 DK DK15738959.4T patent/DK3158337T3/da active
- 2015-06-18 EP EP15738959.4A patent/EP3158337B1/en active Active
- 2015-06-18 ES ES15738959T patent/ES2728669T3/es active Active
- 2015-06-18 EP EP19160490.9A patent/EP3517958B1/en active Active
- 2015-06-18 DK DK19160490.9T patent/DK3517958T3/da active
- 2015-06-18 PL PL15738959T patent/PL3158337T3/pl unknown
- 2015-06-18 HU HUE19160490A patent/HUE052117T2/hu unknown
- 2015-06-18 US US15/319,515 patent/US10877034B2/en active Active
-
2020
- 2020-11-23 US US17/101,693 patent/US12007391B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015193552A2 (en) | 2015-12-23 |
| HUE052117T2 (hu) | 2021-04-28 |
| PL3158337T3 (pl) | 2019-08-30 |
| EP3158337A2 (en) | 2017-04-26 |
| EP3517958A1 (en) | 2019-07-31 |
| US20210080458A1 (en) | 2021-03-18 |
| ES2728669T3 (es) | 2019-10-28 |
| EP3158337B1 (en) | 2019-03-06 |
| US10877034B2 (en) | 2020-12-29 |
| WO2015193552A3 (en) | 2016-03-24 |
| DK3517958T3 (da) | 2020-10-12 |
| EP3517958B1 (en) | 2020-08-12 |
| PL3517958T3 (pl) | 2021-04-19 |
| ES2825573T3 (es) | 2021-05-17 |
| US20170160276A1 (en) | 2017-06-08 |
| US12007391B2 (en) | 2024-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3548652T3 (da) | Fremgangsmåder til proteinanalyse | |
| DK3497207T3 (da) | Fremgangsmåder til påvisning af aav | |
| DK3436998T3 (da) | Instrument til overvågning af en analytkoncentration | |
| DK3292137T3 (da) | Proteiner specifikke for cd137 | |
| HK1258925A1 (zh) | 用於確定分析物濃度的套件 | |
| DK3224755T3 (da) | Statistisk analysefremgangsmåde til bestemmelse af risiko ved filbaseret indhold | |
| DK3332006T3 (da) | Hidtil ukendte anti-PD-L1-antistoffer | |
| DK3556775T3 (da) | Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter | |
| DK3268391T3 (da) | Fremgangsmåder til reduktion af serumniveauer af Fc-indeholdende midler ved anvendelse af FcRn-antagonister | |
| DK3201361T3 (da) | Fremgangsmåder til kvantificering af cellefrit DNA | |
| DK3384274T3 (da) | Fremgangsmåder til prøvekarakterisering | |
| DK3563156T3 (da) | Fremgangsmåde til separering af biomolekyler | |
| DK3365791T3 (da) | Teknikker til bestemmelse af virkningerne på klientsiden af adfærd på serversiden ved hjælp af kontrolværdianalyse | |
| DK3060582T3 (da) | Assays til bestemmelse af plasmakallikreinsystem-biomarkører | |
| DK3314010T3 (da) | Fremgangsmåde til detektering af kromosomaberrationer | |
| DK3304093T3 (da) | Validering af biomarkørmåling | |
| DK3014279T3 (da) | Fremgangsmåde til bestemmelse af proteinaggregater under anvendelse af overflade-fida | |
| DK2970379T3 (da) | Fremgangsmåder til forhøjelse af proteinrenhed ved anvendelse af protein a-baseret kromatografi | |
| DK3218396T3 (da) | Fremgangsmåde til fremstilling af højaffinitets antistoffer | |
| DK3340796T3 (da) | Sonder til afbildning af huntingtin-protein | |
| IL255094A0 (en) | A method for increasing the percentage of multimeric strains for a monomeric dsfv-fab antibody | |
| DK3384045T3 (da) | Fremgangsmåde til bestemmelse af celleklonalitet | |
| DK3748358T3 (da) | Cellebaseret fremgangsmåde til bestemmelse af virkningsgraden af defibrotid | |
| DK3144681T3 (da) | Prøveanalyseindretning | |
| DK3123175T3 (da) | Fremgangsmåde til at identificere en biomarkør, der indikerer en reduceret lægemiddelrespons under anvendelse af et termisk shift assay |